OptiCept Technologies
OptiCept Technologies recruits a new CFO
OptiCept Technologies recruits Déspina Georgiadou Hedin as the company's new CFO. Déspina most recently comes from Ascelia Pharma AB (publ), a biotech company listed on Nasdaq, where she held the position of CFO. She will take up her position no later than 1 November 2023.
Déspina Georgiadou Hedin now replaces Tomas Andersson, who acted as interim CFO since April 2023 while a permanent recruitment was carried out. She has extensive experience in leading positions in finance and the role of CFO for both listed and unlisted companies. Most recently, she was the CFO at Ascelia Pharma AB and before that, she was, among other things, CFO and HR manager at Bioglan AB, as well as Chief Accountant and Senior Financial Specialist at Sol Voltaics AB. Déspina has a bachelor's degree in economics from Linnaeus University, Växjö/Kalmar.
"We are very happy to welcome Déspina to OptiCept as CFO. She has a strong profile and solid experience, not least from working with companies on Nasdaq's small-cap list, which we have ambitions to list ourselves on. I also want to thank Tomas Andersson who has done an excellent job during his time as interim CFO.” says Thomas Lundqvist, CEO of OptiCept Technologies.
"OptiCept is a very exciting company with an innovative product portfolio with a strong sustainability profile. I am very much looking forward to starting at OptiCept and being able to contribute to the company's development and future growth". Says CFO Déspina Georgiadou Hedin.
| Datum | 2023-10-20, kl 15:00 |
| Källa | MFN |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!